Table 3. Multivariate analysis for factors associated with presentation delay > 14 days.
| Variables | ≤ 14 days (n = 843) | > 14 days (n = 714) | P value | Multivariate analysis | |
|---|---|---|---|---|---|
| aOR (95% CI) | P value | ||||
| During-COVID-19 group | 469 (55.6) | 364 (51.0) | 0.067 | 0.884 (0.715–1.094) | 0.257 |
| Age ≥ 65 years | 463 (54.9) | 306 (42.9) | < 0.001 | 0.658 (0.529–0.819) | < 0.001 |
| Male | 511 (60.6) | 414 (58.0) | 0.292 | 0.910 (0.731–1.133) | 0.400 |
| Prior TB treatment | 140 (16.6) | 113 (15.8) | 0.677 | 0.919 (0.689–1.227) | 0.590 |
| Extrapulmonary involvement | 316 (37.5) | 225 (31.5) | 0.014 | 1.070 (0.837–1.366) | 0.567 |
| Cough ± sputum | 363 (43.1) | 466 (65.3) | < 0.001 | 2.454 (1.945–3.095) | < 0.001 |
| Fever | 232 (27.5) | 95 (13.3) | < 0.001 | 0.375 (0.285–0.494) | < 0.001 |
| Alarming symptomsa | 380 (45.1) | 229 (32.1) | < 0.001 | 0.604 (0.484–0.753) | < 0.001 |
| Diabetes | 192 (22.8) | 128 (17.9) | 0.018 | 0.828 (0.632–1.084) | 0.170 |
| Solid malignancy | 67 (7.9) | 40 (5.6) | 0.068 | 0.848 (0.551–1.304) | 0.452 |
Values are expressed as numbers and percentage.
COVID-19 = coronavirus disease 2019, aOR = adjusted odds ratio, CI = confidence interval, TB = tuberculosis.
aAlarming symptoms were defined as sum of chest discomfort, hemoptysis, or dyspnea.